The introduction of Retatrutide in the United Kingdom is generating significant excitement within the obesity community. This groundbreaking dual compound – targeting both GLP-1 and GIP – suggests a potentially new strategy to addressing excess weight . Until recently, options have been restricted for many, and Retatrutide embodies a promising